Item 8.01. Other Events

Walgreen Co. ("Walgreens"), a subsidiary of Walgreens Boots Alliance, Inc. (together with Walgreens, the "Company"), issued a press release today announcing that it has entered into a settlement agreement with the State of Florida to resolve claims related to prescriptions for opioid medications that were filled at Walgreens pharmacy locations in Florida. Under the terms of the settlement agreement, the Company will settle all opioid claims against it by the State of Florida for $683 million, which includes $620 million to be paid to the State of Florida over 18 years as well as a one-time payment of $63 million for attorneys' fees. The settlement includes no admission of wrongdoing or liability by the Company.

A copy of the press release is attached hereto as Exhibit 99.1 and incorporated by reference herein.

Item 9.01. Financial Statements and Exhibits.



(d) Exhibits

Exhibit                                     Description

99.1          Press Release of Walgreens Boots Alliance, Inc. dated May 5, 2022

104         Cover Page Interactive Data File (embedded within the Inline XBRL document)

Cautionary Note Regarding Forward-Looking Statements

All statements in this report that are not historical including, without limitation, those regarding payments anticipated to be made pursuant to the settlement agreement, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words such as "expect," "will," "likely," "intend," "plan," "aim," "continue," "believe," "seek," "anticipate," "upcoming," "may," "possible," and variations of such words and similar expressions are intended to identify such forward-looking statements.

These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions, known or unknown, that could cause actual results to vary materially from those indicated or anticipated. These risks, assumptions and uncertainties include those described in Item 1A (Risk Factors) of our Annual Report on Form 10-K for the fiscal year ended August 31, 2021 and in other documents that we file or furnish with the Securities and Exchange Commission. If one or more of these risks or uncertainties materializes, or if underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. All forward-looking statements we make or that are made on our behalf are qualified by these cautionary statements. Accordingly, you should not place undue reliance on these forward-looking statements, which speak only as of the date they are made.

We do not undertake, and expressly disclaim, any duty or obligation to update publicly any forward-looking statement after the date of this release, whether as a result of new information, future events, changes in assumptions or otherwise.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses